BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8747754)

  • 1. Effects of noncompetitive N-methyl-D-aspartate receptor antagonists on opiate tolerance and physical dependence.
    Trujillo KA
    Neuropsychopharmacology; 1995 Dec; 13(4):301-7. PubMed ID: 8747754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Medication development issues for opiate addiction.
    Herman BH; Vocci F; Bridge P
    Neuropsychopharmacology; 1995 Dec; 13(4):269-93. PubMed ID: 8747752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blockade of opioid tolerance and dependence by NMDA receptor antagonist].
    Zang MW; Liu JS
    Sheng Li Ke Xue Jin Zhan; 1999 Jul; 30(3):207-13. PubMed ID: 12532781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of opiate tolerance by non-competitive N-methyl-D-aspartate receptor antagonists.
    Trujillo KA; Akil H
    Brain Res; 1994 Jan; 633(1-2):178-88. PubMed ID: 8137155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [NMDA-receptor antagonists: new pharmacological agents to control the subjective and motivational effects of narcotics].
    Bespalov AIu; Zvartau EE
    Vestn Ross Akad Med Nauk; 1998; (11):24-9. PubMed ID: 9889701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opiate physical dependence and N-methyl-D-aspartate receptors.
    Noda Y; Nabeshima T
    Eur J Pharmacol; 2004 Oct; 500(1-3):121-8. PubMed ID: 15464026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development.
    Elliott K; Kest B; Man A; Kao B; Inturrisi CE
    Neuropsychopharmacology; 1995 Dec; 13(4):347-56. PubMed ID: 8747759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMDA receptor antagonists inhibit opiate antinociceptive tolerance and locomotor sensitization in rats.
    Mendez IA; Trujillo KA
    Psychopharmacology (Berl); 2008 Feb; 196(3):497-509. PubMed ID: 17994223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives on the N-methyl-D-aspartate/nitric oxide cascade and opioid tolerance.
    Pasternak GW; Kolesnikov YA; Babey AM
    Neuropsychopharmacology; 1995 Dec; 13(4):309-13. PubMed ID: 8747755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of morphine withdrawal by the NMDA receptor antagonist MK-801 in rat is age-dependent.
    Zhu H; Barr GA
    Synapse; 2001 Jun; 40(4):282-93. PubMed ID: 11309844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opiate tolerance and dependence: recent findings and synthesis.
    Trujillo KA; Akil H
    New Biol; 1991 Oct; 3(10):915-23. PubMed ID: 1662985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of the number of NMDA receptors in the development of supersensitivity or tolerance to and dependence on morphine.
    Koyuncuoglu H; Nurten A; Yamantürk P; Nurten R
    Pharmacol Res; 1999 Apr; 39(4):311-9. PubMed ID: 10208762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repetitive opioid abstinence causes progressive hyperalgesia sensitive to N-methyl-D-aspartate receptor blockade in the rat.
    Dunbar SA; Pulai IJ
    J Pharmacol Exp Ther; 1998 Feb; 284(2):678-86. PubMed ID: 9454814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective use of N-methyl-D-aspartate receptor antagonists as a spinoplegia against excitatory amino acid neurotoxicity.
    Cho Y; Ueda T; Mori A; Shimizu H; Haga Y; Yozu R
    J Vasc Surg; 2005 Oct; 42(4):765-71. PubMed ID: 16242566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the locus coeruleus and N-methyl-D-aspartic acid (NMDA) and AMPA receptors in opiate withdrawal.
    Rasmussen K
    Neuropsychopharmacology; 1995 Dec; 13(4):295-300. PubMed ID: 8747753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Methyl-D-aspartate receptor antagonists and the development of tolerance to the discriminative stimulus effects of morphine in rats.
    Bespalov AY; Balster RL; Beardsley PM
    J Pharmacol Exp Ther; 1999 Jul; 290(1):20-7. PubMed ID: 10381755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are NMDA receptors involved in opiate-induced neural and behavioral plasticity? A review of preclinical studies.
    Trujillo KA
    Psychopharmacology (Berl); 2000 Aug; 151(2-3):121-41. PubMed ID: 10972459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naltrexone-precipitated morphine withdrawal in infant rat is attenuated by acute administration of NOS inhibitors but not NMDA receptor antagonists.
    Zhu H; Barr GA
    Psychopharmacology (Berl); 2000 Jun; 150(3):325-36. PubMed ID: 10923761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of morphine dependence and withdrawal by glycine B site antagonists in rats.
    Kotlińska J
    Pharmacol Biochem Behav; 2001 Jan; 68(1):157-61. PubMed ID: 11274720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
    Witkin JM; Steele TD; Sharpe LG
    J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.